Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Orion launches entacapone in first markets and updates safety information

Dec. 1, 1998

Naphthylpiperazine antipsychotics synthesized at Faes

Dec. 1, 1998

Guilford presents two new series of NAALADase inhibitors

Nov. 30, 1998

Unimed receives U.S. patent protection for dronabinol in treatment of dementia

Nov. 30, 1998

SSRI promising in the treatment of children and adolescents with OCD

Nov. 30, 1998

International study focuses on riluzole as a new approach to treating PD

Nov. 30, 1998

Nortran announces positive phase II trial results with RSD-921

Nov. 30, 1998

Human neural stem cells as source of transplantable cells for CNS disorders

Nov. 26, 1998

Grape polyphenols now shown to have neuroprotective properties

Nov. 26, 1998

Pharmacological profile of PNU-99194A, a D3-preferring dopamine antagonist, reviewed

Nov. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...